cui,preferred_name
C0211067,PAVe protocol 1
C0029347,influenza A virus
C0035243,Respiratory Tract Infections
C0004611,Bacteria
C1880253,Data Port
C0282111,Internet
C1513843,NIH Mouse
C1705803,National Center for Biotechnology Information
C0027470,National Library of Medicine (U.S.)
C0221055,Paramyotonia Congenita (disorder)
C1419208,RAB3D gene
C1706852,Article
C3812881,Author
C1551744,Nikolai Indians
C1551054,Units Of Measure - Siemens
C0011008,Date in time
C4724436,Dogri Language
C3842590,10%
C3538933,C-Circle
C1550439,Entity Name Use - License
C0086418,Homo sapiens
C0009450,Communicable Diseases
C0521009,Bacterial
C3245499,Colombia
C2603343,Study
C0819757,Structure of parenchyma of lung
C0032285,Pneumonia
C0376554,Knowledge
C3161035,Model
C0877203,Viral Respiratory Tract Infection
C0729531,Viral respiratory infection
C0597295,Protein Biosynthesis
C2825142,Experimental Result
C1880355,Discover
C1704913,TAF1 wt Allele
C0600678,Abstract Summary
C0003062,Animals
C0085979,Cavia
C0012634,Disease
C0878517,Engineer
C2826244,Life Threatening
C0449295,Limitation
C0458579,Lower respiratory tract structure
C0026809,Mus
C0324889,Old World rabbit
C0150312,Present
C0034721,Rattus
C0282443,Review [Publication Type]
C1318973,Staphylococcus aureus infection
C0038410,Streptococcus pneumoniae
C0038411,Streptococcus pyogenes
C0041260,Tryptophanase
C0029347,influenza A virus
C1705535,suggestion
C0035243,Respiratory Tract Infections
C0275524,Coinfection
C0440744,Human tissue
C0470187,Availability of
C0015859,Ferrets
C0018684,Health
C1709743,Protein Turn
C0042776,Virus
C1518422,Negation
C0033147,Primates
C4055445,Approved for Human Use Product
C2986594,Mouse Model
C0725066,Advance -- medical device
C3900053,Amenable
C0162340,Comprehension
C0040722,disease transmission qualifier
C2348269,Dietary Lead
C0205221,Disseminated
C1517378,Gain
C4084912,Importance Rating Score 0
C1708698,Light Emitting Diode Device
C0947630,Scientific Study
C0205082,Severe (severity modifier)
C1880177,Contribution
C1704243,Greater
C1285542,Has focus
C1397014,Imbalance
C2828008,Burden
C0039005,Family suidae
C0439601,Seasonal course
C2348480,ex vivo
C0521346,respiratory
C0458578,Upper respiratory tract
C0086272,Experimental Model
C0024109,Lung
C1706701,Acquisition (action)
C0521116,Current (present time)
C3245505,Potential
C0009462,Community
C0332183,Frequently
C2348867,Global
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C1956108,Microbiome
C0486616,Composition
C1542147,Main
C0521009,Bacterial
C0027442,Nasopharynx
C0205172,More
C0041260,Tryptophanase
C0012634,Disease
C1521761,Factor
C1000792,Microbiota (plant)
C1705920,Species
C0038410,Streptococcus pneumoniae
C0014406,Environment
C0445623,Microorganism
C0729333,Dynamic
C0032285,Pneumonia
C3840556,Murphy
C0332185,Recent
C0086418,Homo sapiens
C1167395,Host (organism)
C0450254,Pathogenic organism
C1442457,2 Weeks
C0001721,Affect (mental function)
C0009450,Communicable Diseases
C0332256,Containing (qualifier)
C0600138,Does play
C1522492,Formation
C4704695,Host Bacteria Interactions
C0332257,Including (qualifier)
C3828954,Most of the time
C1554111,Text - MDFAttributeType
C0332289,Transmitted by
C0458578,Upper respiratory tract
C0683454,internal-external locus of control scale
C1547282,Show
C0020962,Immune system
C1148523,Childbirth
C0541749,Does turn (finding)
C0231290,Status post
C0521026,Viral
C0439231,month
C0439234,year
C0332281,Associated with
C2061911,Mixed Flora
C0035204,Respiration Disorders
C0038172,Staphylococcus aureus
C2242554,Streptococcus colonisation
C0001792,Elderly (population group)
C0178685,human morbidity
C4484138,week 1
C1706701,Acquisition (action)
C0205265,Initially
C3887843,Microbiota (environment)
C0023175,lead
C2699153,Cell Invasion
C4289767,Colonization
C0009462,Community
C1707903,Embedding
C0680063,Offspring
C1273518,Responsible to
C0947630,Scientific Study
C0231202,Symbiotic
C0035820,Social Role
C1140704,Streptococcus viridans
C1397014,Imbalance
C0038170,Genus staphylococcus
C0205250,High
C0205314,New
C0205082,Severe (severity modifier)
C0521346,respiratory
C0392747,Changing
C0205252,Immature
C0402830,Miller
C0392674,Exhaustion
C0021289,"Infant, Newborn"
C0750554,MOSTLY
C0026565,Mortality Vital Statistics
C3245505,Potential
C0001779,Age
C0699748,Pathogenesis
C0750503,around
C0004611,Bacteria
C0205296,Natural
C1704913,TAF1 wt Allele
C1979963,Profile (lab procedure)
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0030705,Patients
C0751985,Proteobacteria
C2825142,Experimental Result
C2986479,Healthy Control
C0936012,Analysis
C0486616,Composition
C0003232,Antibiotics
C0205171,Singular
C0032285,Pneumonia
C0580264,H1N1
C1456432,Actinobacteria phylum
C0001779,Age
C0332282,Following
C0079399,Gender
C0332257,Including (qualifier)
C0026809,Mus
C1441672,Observed
C0443289,Revealed
C2603343,Study
C0392366,Tests (qualifier value)
C0439828,Variable (uniformity)
C0001563,"Administration, Oral"
C0020964,Immunity
C1000792,Microbiota (plant)
C0199779,Administration of antibiotic
C1615608,Pandemics
C0009450,Communicable Diseases
C1397014,Imbalance
C2346714,Abundance
C1707455,Comparison
C0178602,Dosage
C0205217,Increased
C1956108,Microbiome
C3842396,No difference
C0456079,Disease classification level
C0221099,Impaired
C1518422,Negation
C1709533,Phylum (taxon)
C2347509,Physical Shift
C0445247,Same
C1704324,Scientific Publication
C4048280,"T-Cell Surface Glycoprotein CD4, human"
C0439508,per year
C0012652,Disease Outbreaks
C0237881,Statistical Significance
C0183683,"Support, device"
C1292748,Introduces
C0004561,B-Lymphocytes
C0521009,Bacterial
C3538720,CD8 Expressing Cell Count
C0029347,influenza A virus
C0231202,Symbiotic
C0521346,respiratory
C1707959,Example
C0205447,One
C1956109,Human Microbiome
C3843765,65+
C0442027,Oral
C1547282,Show
C0521367,Oropharyngeal
C1517320,From
C0439662,Immune
C1519068,Phylogenetic Analysis
C1704675,Interaction
C1285542,Has focus
C0521009,Bacterial
C1947900,"Death Due to Disease Progression Not Associated with More Specific Term NOS, CTCAE"
C2584313,Discussion (communication)
C1171285,Enabling
C0127400,Mediator brand of benfluorex hydrochloride
C1999230,Providing (action)
C0282443,Review [Publication Type]
C0557651,Room of building - Study
C0041260,Tryptophanase
C1261959,Bacterial infections of the respiratory tract
C0686907,Consequence of
C0679199,Strategy
C0948192,primary infection nos
C0301872,Immune response
C0233820,Insight
C3900053,Amenable
C0392673,Adaptation
C0205470,immunologic
C0521026,Viral
C0599779,Animal Model
C0275524,Coinfection
C1880177,Contribution
C1167395,Host (organism)
C0332287,In addition to
C0441712,Mechanism (attribute)
C0687676,Post
C0231221,Asymptomatic
C4289767,Colonization
C1517331,Further
C3245505,Potential
C0175668,Secondary to
C0205250,High
C3151529,Lethal
,
,
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0021403,Influenza virus vaccine
C0018909,Hemagglutinin
C0027803,Neuraminidase
C0029347,influenza A virus
C0001779,Age
C0237401,Individual
C0439601,Seasonal course
C0439858,Conventional
C3843765,65+
C0005595,Aves
C0001792,Elderly (population group)
C0019944,Equus caballus
C0750572,Estimated
C1704243,Greater
C0086418,Homo sapiens
C0332257,Including (qualifier)
C0205447,One
C0029341,Orthomyxoviridae
C0162735,Point Mutation
C0033011,Pregnant Women
C0035647,Risk
C0339952,Secondary bacterial pneumonia
C1135183,Sus scrofa
C0041260,Tryptophanase
C3538928,Usual
C0043528,Zoonoses
C1881534,Make - Instruction Imperative
C1883712,Add - instruction imperative
C3898900,Healthy
C3245505,Potential
C0011065,Cessation of life
C0449560,Subtype (attribute)
C0332294,Resulting in
C0205419,Variant
C0003062,Animals
C0686907,Consequence of
C0014499,Epidemic
C1518614,Organism Strain
C2699488,Resolution
C0242781,disease transmission
C1705938,Base - General Qualifier
C0015576,Family
C0680063,Offspring
C2698667,Other Toxicity Studies: Antigenicity
C1880022,Characterization
C0008902,Classification
C1546944,Event Seriousness - Significant
C0678558,Plasticity
C4517521,10.5
C0017428,Genome
C1280500,Effect
C0032659,geographic population
C4484002,Influenza season
C1615608,Pandemics
C3816747,500
C0332181,Annual
C2346866,Assortment
C1441547,Derivation
C0441471,Event
C1708004,FAT1 wt Allele
C0574447,Kongo language
C0205314,New
C0556581,Retinol equivalents
C0557775,Van (physical object)
C0009488,Comorbidity
C0441635,Anatomical segmentation
,
,
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0021400,Influenza
C0444675,Shank
C1615608,Pandemics
C0032285,Pneumonia
C0027361,Persons
C0521009,Bacterial
C0038410,Streptococcus pneumoniae
C1306577,Death (finding)
C1524003,Science of Etiology
C1709305,Occur (action)
C0205393,Most
C0450254,Pathogenic organism
C0078988,Asians
C0205082,Severe (severity modifier)
C0019907,Hong Kong
C2987742,Hong Kong Zebrafish
C0220888,increasing incidence
C0038172,Staphylococcus aureus
C0038411,Streptococcus pyogenes
C0205419,Variant
C1615607,"Influenza A Virus, H1N1 Subtype"
C4738113,Fatalities
C0332183,Frequently
C1533148,Case unit dose
C0439234,year
C0175668,Secondary to
C1542147,Main
C1707455,Comparison
C3843766,<50
C0017446,Geographic Locations
C1517892,Links List
C1705232,Death Related to Adverse Event
C0086409,Hispanics
C1704913,TAF1 wt Allele
C0700364,Appearance
C0005595,Aves
C0011065,Cessation of life
C0746102,Chronic lung disease
C0205848,Death Rate
C1947931,Direct (qualifier)
C0750572,Estimated
C0018483,Haemophilus influenzae
C0020538,Hypertensive disease
C0205396,Identified
C0332257,Including (qualifier)
C0205409,Isolated
C0026565,Mortality Vital Statistics
C0282416,Overall Publication Type
C0004626,"Pneumonia, Bacterial"
C1257890,Population Group
C0456962,Rapid
C0035237,Respiratory System
C0035439,Rheumatic Heart Disease
C0521117,Severity of illness
C1318973,Staphylococcus aureus infection
C0750591,consider
C0683454,internal-external locus of control scale
C1705535,suggestion
C0008679,Chronic disease
C0007465,Cause of Death
C0332281,Associated with
C0035222,"Respiratory Distress Syndrome, Adult"
C0439092,Less Than
C1518614,Organism Strain
C0750492,Probably
C0947630,Scientific Study
C1705920,Species
C0205251,low
C0012634,Disease
C0040223,Time
C0020964,Immunity
C0004623,Bacterial Infections
C0580265,H2N2
C0275524,Coinfection
C0339965,Hemorrhagic pneumonia
C1853237,Isolated cases
C3245499,Colombia
C4517906,95
C0009566,Complication
C0678226,Due to
C0205087,Late
C0042776,Virus
C1511726,Data
C3714514,Infection
C0439801,Limited (extensiveness)
C0439064,Numerous
C2926606,Procedure findings:Finding:Point in time:^Patient:Narrative
C0332185,Recent
C0332156,Return to (contextual qualifier) (qualifier value)
C0205437,Third
C1710548,Unique
C0220856,incidence of cases
C0332232,Approximate
C3898900,Healthy
C0549177,Large
C0332239,Young
C0725813,depend
C1881839,1000000
C0162388,Killing
C0205329,Progressive
C2741673,Account number:Identifier:Point in time:^Patient:Nominal
C4021610,Bilateral lung agenesis
C0449234,Concept Attribute
C0205423,Certain (qualifier value)
C3816449,Forty
C0580264,H1N1
C1947913,Local-Regional anatomy
C4698491,Rather
C4722602,Underlying
C0332282,Following
C0205166,Long
C3687536,Martin
C1509547,Rice Preparation
C0205448,Two
C0580267,H3N2
C1955473,Others - Allergy
C0439793,Severities
C0205276,Local
C0205314,New
C1135183,Sus scrofa
C0079429,"Genes, vif"
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0332257,Including (qualifier)
C0521009,Bacterial
C0450254,Pathogenic organism
C0027442,Nasopharynx
C0086418,Homo sapiens
C4084912,Importance Rating Score 0
C1521970,Characteristics
C4289767,Colonization
C0600138,Does play
C3887511,Evidence
C0017110,Gases
C0442808,Increasing
C0597404,Respiratory viruses
C0237876,Sharing (Social Behavior)
C0038172,Staphylococcus aureus
C0038410,Streptococcus pneumoniae
C0041260,Tryptophanase
C0683325,clinical aspects
C1547282,Show
C0339901,Acute respiratory infections
C1443953,Acute viral disease
C0877203,Viral Respiratory Tract Infection
C0392747,Changing
C0442886,Secondary Infections
C0004623,Bacterial Infections
C1510802,Adherence (attribute)
C0441712,Mechanism (attribute)
C1000792,Microbiota (plant)
C0871161,Property (attribute)
C0521026,Viral
C0521346,respiratory
C4699158,Increased risk
C1522538,Leading
C0035820,Social Role
C1710548,Unique
C0175668,Secondary to
C0035853,Rosa
C0205178,acute
C0017480,Germany
C1514241,Positive Finding
C0439208,gram
C4321249,DIAPH3 wt Allele
C0332183,Frequently
C0543483,pathogenic aspects
,
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C1524003,Science of Etiology
C0205082,Severe (severity modifier)
C0003232,Antibiotics
C2700399,Include (action)
C4521538,Methicillin-resistant Staphylococcus aureus Measurement
C1456808,"Nares, entire, anterior or posterior"
C1948052,Now (temporal qualifier)
C0450254,Pathogenic organism
C1123023,Skin
C1318973,Staphylococcus aureus infection
C0004454,Axilla
C0264515,"Pneumonia, Necrotizing"
C0033522,Prospective Studies
C0009013,Clone Cells
C2981279,Decade
C0332281,Associated with
C4050419,Borg Category-Ratio 10 Perceived Exertion Score 7
C0332325,Resistant (qualifier value)
C0037278,"Skin Diseases, Infectious"
C0683626,human group
C2699424,Concern
C3812801,Immunogenicity Specimen Assessments Domain
C0442805,Increase
C0205555,Special
C2346866,Assortment
C3714514,Infection
C2945599,Mild (qualifier value)
C3842588,30%
C0750508,persistently
C4321377,Relational and Item-Specific Encoding Task
C1514721,Range
C0205423,Certain (qualifier value)
C1517741,Last
C3538928,Usual
C1705232,Death Related to Adverse Event
C0332185,Recent
C0557775,Van (physical object)
C0205721,"Infections, Hospital"
C1280464,Manifestation of
C0456394,Community acquired
C4321249,DIAPH3 wt Allele
C1709707,Proportion
C0205210,Clinical
C0442808,Increasing
C0237753,Numbers
C0456178,Microbiology subtype strains
C2347565,Case Sensitive
C1704913,TAF1 wt Allele
C0025643,methicillin
C1449520,Pulmonal S
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0004610,Bacteremia
C0004611,Bacteria
C0008059,Child
C0009763,Conjunctivitis
C0001792,Elderly (population group)
C0332257,Including (qualifier)
C0025289,Meningitis
C0029882,Otitis Media
C0038410,Streptococcus pneumoniae
C1859430,Life-threatening infections
C0032269,Pneumococcal Infections
C0032285,Pneumonia
C0332281,Associated with
C0027361,Persons
C0205082,Severe (severity modifier)
C0205848,Death Rate
C5191358,30.8
C4699271,20/50
C0686750,Well adult
C0683454,internal-external locus of control scale
C1299351,Abnormally high
C0026538,Morbidity - disease rate
C0686744,Well child
C0332232,Approximate
C2945599,Mild (qualifier value)
C0037199,Sinusitis
C1514721,Range
C0085393,Immunocompromised Host
C0005680,Black race
C1524003,Science of Etiology
C0041260,Tryptophanase
C0242444,Population at Risk
C0086418,Homo sapiens
C0027442,Nasopharynx
C3538928,Usual
C0226896,Oral cavity
C0038411,Streptococcus pyogenes
C0040425,Tonsillitis
C0439508,per year
C3714514,Infection
C0205303,Non-invasive
C0032659,geographic population
C0202311,Aluminum measurement
C0458578,Upper respiratory tract
C0017110,Gases
C1524003,Science of Etiology
C0031350,Pharyngitis
C2945599,Mild (qualifier value)
C0040028,"Thrombocythemia, Essential"
C0205393,Most
C1522138,shared attribute
C1881839,1000000
C3816748,600
C1533148,Case unit dose
C0750572,Estimated
C0202311,Aluminum measurement
C0745732,List
C0040028,"Thrombocythemia, Essential"
C0470277,2000
C0332257,Including (qualifier)
C0450254,Pathogenic organism
C0032285,Pneumonia
C1524003,Science of Etiology
C0243026,Sepsis
C0343532,Streptococcal toxic shock syndrome
C0037278,"Skin Diseases, Infectious"
C5139167,Severe infection
C0205455,Nine
C0237753,Numbers
C3816747,500
C0332181,Annual
C1306577,Death (finding)
C0332287,In addition to
C0205281,Invasive
C0439664,Necrotizing
C1707101,CD44 wt Allele
C2348867,Global
C1336644,TNFRSF10B gene
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C1524003,Science of Etiology
C0041260,Tryptophanase
C0085732,Ability
C0001779,Age
C0750572,Estimated
C3887642,Hippocampus Proper
C1999167,Old age
C0038410,Streptococcus pneumoniae
C0237401,Individual
C1705232,Death Related to Adverse Event
C0012634,Disease
C0450254,Pathogenic organism
C2945640,compromise
C3844029,Child 5
C3842590,10%
C0011065,Cessation of life
C0205393,Most
C0205449,Three
C0205250,High
C3151529,Lethal
C0332285,Within
C0439234,year
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C1515877,activate biological process
C1879648,Alpha2 Significance
C1879547,Activation action
C0205263,Induce (action)
C1167622,Binding (Molecular Function)
C1283071,Release - action (qualifier value)
C0814942,Han Chinese
C0042776,Virus
C0037025,Sialic Acids
C0042769,Virus Diseases
C0030946,Endopeptidases
C0521026,Viral
C0035736,"RNA, Viral"
C0557775,Van (physical object)
C0333348,Inflammatory
C1517892,Links List
C0005595,Aves
C0009450,Communicable Diseases
C1383501,Cytoplasmic matrix
C0439851,Direct type of relationship
C2349975,Enhance (action)
C0015127,Etiology aspects
C0441471,Event
C1539598,GPRC5A gene
C0018563,Hand
C0205217,Increased
C3815172,Interleukin 1 Beta Measurement
C0458579,Lower respiratory tract structure
C0033414,Promotion (action)
C1999230,Providing (action)
C0871261,Response process
C1547282,Show
C0041260,Tryptophanase
C0120446,guanidine
C0029347,influenza A virus
C3849701,"interleukin 18 protein, human"
C0021753,"interleukin-1, beta"
C2945617,yang
C1155266,Inflammatory Response
C0332294,Resulting in
C0005778,Blood coagulation
C2825073,Clearance [PK]
C0332287,In addition to
C0080194,Muscle strain
C0079904,NF-kappa B
C1417708,NFKB1 gene
C1709743,Protein Turn
C1567060,"RELA protein, human"
C1522537,Recombinant Interferon
C1272318,Presence of virus (procedure)
C0004611,Bacteria
C0871208,Rating (action)
C1148846,RNA Binding
C0858744,infection induced
C1704259,Biochemical Pathway
C0819757,Structure of parenchyma of lung
C4552279,Tissue injury
C0273115,Lung Injury
C0162638,Apoptosis
C1273342,Epithelial cell count (procedure)
C1160693,viral release from host cell
C1327413,cytokine production
C3272629,Epithelial Damage
C0067762,N-Acetylneuraminic Acid
C1510827,Affinity
C0181586,Leads (device)
C0040300,Body tissue
C1880177,Contribution
C0185117,Expression procedure
C0086418,Homo sapiens
C0024109,Lung
C0027540,Necrosis
C0040578,Trachea
C3263722,Traumatic AND/OR non-traumatic injury
C0014406,Environment
C0042765,Virulence
C0443127,Aberrant
C0598312,DNA Replication
C3844638,Either
C0301872,Immune response
C2936529,Inflammasomes
C0439070,Roman Numeral III
C0439601,Seasonal course
C0040648,TRANSCRIPTION FACTOR
C0424295,Hyperactive behavior
C3269136,extrinsic apoptotic signaling pathway
C1705242,Different
C0441729,Type 1
C1337068,viral genome location
C0678226,Due to
C0042774,Virus Replication
C0439674,Intrinsic origin
C0029341,Orthomyxoviridae
C3538928,Usual
C0449475,cell type
C0014609,Epithelium
C0033684,Proteins
C1550513,via
C0017428,Genome
C0035668,RNA
C1704913,TAF1 wt Allele
C1282910,Upper
C0079189,cytokine
C0033382,proline
C1999228,Attachments (document)
C0521009,Bacterial
C0006539,Belarus
C1167395,Host (organism)
C1555582,Initial (abbreviation)
C1367553,PLG gene
C0205148,Surface
C1327616,Cell secretion
C1947931,Direct (qualifier)
C2827736,3+ Score
C1440080,Alveolar
C1710602,VIPR1 wt Allele
C0521009,Bacterial
C0332257,Including (qualifier)
C2603343,Study
C0041260,Tryptophanase
C0020962,Immune system
C3853906,Digital Model Attachment
C0009450,Communicable Diseases
C3245499,Colombia
C0086418,Homo sapiens
C1706515,Matrix substance
C0449445,Approach
C3826168,Human physiology
C3828842,Nearly
C1518422,Negation
C0032285,Pneumonia
C0038172,Staphylococcus aureus
C0038410,Streptococcus pneumoniae
C0038411,Streptococcus pyogenes
C0596171,Tissue Engineering
C1282910,Upper
C1524063,Use of
C0683454,internal-external locus of control scale
C1705535,suggestion
C5139167,Severe infection
C0442886,Secondary Infections
C0042769,Virus Diseases
C0004623,Bacterial Infections
C0275524,Coinfection
C0086272,Experimental Model
C0003737,Architecture
C0486616,Composition
C3245505,Potential
C1705920,Species
C0819757,Structure of parenchyma of lung
C0877203,Viral Respiratory Tract Infection
C0729531,Viral respiratory infection
C0004611,Bacteria
C0449432,Component object
C0567416,Molecule
C0370003,Specimen
C0678594,Structure
C0869040,use studies
C4699158,Increased risk
C0861064,lead increased
C3842583,80%
C0520510,Materials
C0026809,Mus
C0884358,Performed
C1273518,Responsible to
C0871532,tool use
C0456369,Proven findings
C0521114,Infrequent
C0035647,Risk
C0172217,arsenal
C0023175,lead
C1515655,In Vivo
C2827734,1+ Score
C1442459,3 Days
C0178539,Cellular
C0039005,Family suidae
C0030705,Patients
C2603362,S prime
C0205449,Three
C2348480,ex vivo
C1704241,complex (molecular entity)
C0001516,Adhesives
C1167395,Host (organism)
C0445623,Microorganism
C0027627,Neoplasm Metastasis
C0439064,Numerous
C0450254,Pathogenic organism
C0439601,Seasonal course
C0205148,Surface
C0521026,Viral
C0458578,Upper respiratory tract
C0678226,Due to
C1136170,Virulence Factors
C1999228,Attachments (document)
C1707391,Choose (action)
C0518609,Consideration
C4321249,DIAPH3 wt Allele
C0026531,Morality
C0178784,Organ
C0332183,Frequently
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0332257,Including (qualifier)
C1709305,Occur (action)
C0521009,Bacterial
C1551054,Units Of Measure - Siemens
C0038410,Streptococcus pneumoniae
C1167395,Host (organism)
C1420002,SFTPA1 gene
C0042769,Virus Diseases
C0332157,Exposure to
C0010957,Tissue damage
C0024109,Lung
C0819757,Structure of parenchyma of lung
C0597357,receptor
C1555582,Initial (abbreviation)
C0470277,2000
C0439659,Beginning
C0031691,ENOLASE
C0562342,Empowered
C0015982,Fibrin
C0016055,Fibronectins
C1414968,GAPDH gene
C0022984,Laminin
C0700271,"M Protein, multiple myeloma"
C0483204,O NOS Ab
C1948045,Once (schedule frequency)
C1418929,PRKG1 gene
C0030705,Patients
C0205148,Surface
C0041260,Tryptophanase
C0683607,allowing
C0009325,collagen
C0016006,fibrinogen
C0041455,collagen type I
C0563640,Bacterial cytotoxin
C0075302,streptolysin S
C0392747,Changing
C0442886,Secondary Infections
C0004623,Bacterial Infections
C0043240,Wound Healing
C2003941,Alpha
C1999228,Attachments (document)
C2699153,Cell Invasion
C0019053,Hemolysin
C0244036,"speB protein, Streptococcus pyogenes"
C4721210,Colonization of lower respiratory tract
C0382507,silver protein preparation
C0205469,Pathological aspects
C0004611,Bacteria
C0449450,Presentation
C0071313,"plY protein, Streptococcus pneumoniae"
C0599732,cell injury
C1155266,Inflammatory Response
C0279023,Chemosensitization
C1314972,Claims attachment
C0023504,Leukocidins
C0033684,Proteins
C0521108,Recovering from
C0521026,Viral
C0441712,Mechanism (attribute)
C0567416,Molecule
C0032285,Pneumonia
C1705920,Species
C1336445,Stage IV Uveal Melanoma AJCC v7
C0205449,Three
C0728940,Excision
C0333348,Inflammatory
C1442792,State
C1548386,Document Completion - incomplete
C0175668,Secondary to
C0023701,Lightning (phenomenon)
C0015350,Extracellular Matrix
C1517331,Further
C1621797,Garcia <plant>
C0442805,Increase
C0017110,Gases
C0067762,N-Acetylneuraminic Acid
C0301872,Immune response
C0038411,Streptococcus pyogenes
C0678723,Biologic Development
C0032140,Plasminogen
C0040044,Thrombolytic Therapy
C1524062,Additional
C1510802,Adherence (attribute)
C0449432,Component object
C0439858,Conventional
C0596901,Membrane
C0027803,Neuraminidase
C3245505,Potential
C1704913,TAF1 wt Allele
C0332273,Through
C0014445,enzymology
,
,
,
,
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0033414,Promotion (action)
C0041260,Tryptophanase
C1709743,Protein Turn
C1515877,activate biological process
C0027950,neutrophil
C0024432,macrophage
C0085236,"Macrophages, Alveolar"
C0085732,Ability
C0205263,Induce (action)
C0024109,Lung
C0038410,Streptococcus pneumoniae
C1522537,Recombinant Interferon
C1442792,State
C0301872,Immune response
C0439180,% release (qualifier value)
C0521026,Viral
C0033268,production
C2825073,Clearance [PK]
C0521009,Bacterial
C0678226,Due to
C0003451,Antiviral Agents
C0332282,Following
C0332257,Including (qualifier)
C0301625,Metabolic Suppression
C0443289,Revealed
C1260953,Suppressed
C2945640,compromise
C1704913,TAF1 wt Allele
C0947630,Scientific Study
C0205421,Deferred
C2349975,Enhance (action)
C2699153,Cell Invasion
C0332287,In addition to
C0035736,"RNA, Viral"
C0441712,Mechanism (attribute)
C0162388,Killing
C1549439,Resident - Procedure Practitioner Identifier Code Type
C1167395,Host (organism)
C0009450,Communicable Diseases
C0079189,cytokine
C0086418,Homo sapiens
C0221099,Impaired
C0700321,Small
C0018154,Gram-Positive Bacteria
C0022688,Natural Killer Cells
C0439662,Immune
C0004611,Bacteria
C0004618,Bacterial Count Measurement
C0007634,Cells
C0162340,Comprehension
C1706214,Creation
C1273342,Epithelial cell count (procedure)
C2709199,Natural killer
C1317556,Natural killer cell function
C1518422,Negation
C1709157,Negative Surgical Margin
C4288581,Notable
C0175566,Open
C1882365,Phenomenon
C0150312,Present
C0750492,Probably
C1999230,Providing (action)
C0035692,"RNA, Bacterial"
C1527036,Recombinant Chemokine
C0038817,Sunlight
C1705581,TLR4 wt Allele
C3538928,Usual
C1523908,apoptotic cell clearance
C0754728,Toll-Like Receptor 2
C1705535,suggestion
C0020969,"Immunity, Innate"
C0427861,Human cells
C0442886,Secondary Infections
C0004623,Bacterial Infections
C0011306,Dendritic Cells
C1299987,Replaced by
C1272746,Change patterns
C0748168,Pulmonary Pathology
C0021368,Inflammation
C0205319,Manifest
C0597484,sodium cation
C1819430,type I interferon production
C0597404,Respiratory viruses
C0812445,CXCL1 gene
C0439640,Dendritic
C0038826,Superinfection
C0085426,Gram-Positive Bacterial Infections
C1704259,Biochemical Pathway
C0185117,Expression procedure
C1155328,Antiviral Response
C1516369,Cellular Infiltration
C3178988,Emergency Responders
C1517886,Limited stage (cancer stage)
C0010957,Tissue damage
C0681828,in vitro study
C1819426,chemokine production
C2754810,monocyte chemotactic protein-1 production
C1160693,viral release from host cell
C2340022,Resting histiocyte
C0007589,Cell Differentiation process
C2949735,Recruitment
C0332294,Resulting in
C0441729,Type 1
C0123759,interleukin-12
C0076930,Transforming Growth Factor beta Receptors
C0861064,lead increased
C3272629,Epithelial Damage
C0332283,Followed by
C1819464,tumor necrosis factor production
C2348269,Dietary Lead
C1271650,Antimicrobial activity
C0014406,Environment
C1272706,Interval
C1622891,Mast cell degranulation
C1705920,Species
C1457868,Worse
C0031843,physiological aspects
C0021743,Interferon Type I
C0205396,Identified
C1522538,Leading
C2905612,Storm NOS
C2603343,Study
C0522505,Upstream
C1440080,Alveolar
C0524637,"Recognition, Psychology"
C0871261,Response process
C1527432,Recombinant Interleukin-8
C0725813,depend
C1332127,AZU1 gene
C0036658,Esthesia
C0004626,"Pneumonia, Bacterial"
C1999228,Attachments (document)
C0012634,Disease
C2828393,Exact (qualifier)
C0017110,Gases
C0205265,Initially
C0439064,Numerous
C0439070,Roman Numeral III
C0332157,Exposure to
C0027365,Name
C0027627,Neoplasm Metastasis
C0450955,Yamamoto
C3495095,lithium cation
C0946292,polarization
C1705242,Different
C4722602,Underlying
C0128897,Monocyte Chemoattractant Protein-1
C1448177,"TNF protein, human"
C0042774,Virus Replication
C0031308,Phagocytosis
C1819995,Host Cell
C1449159,"CCL2 protein, human"
C3714514,Infection
C0567416,Molecule
C0450254,Pathogenic organism
C0220898,Predisposition -- attribute
C0035668,RNA
C4722001,Substance with effector mechanism of action (substance)
C0282554,chemokine
C0183210,sensor (device)
C4321249,DIAPH3 wt Allele
C0162493,Transcriptional Activation
C0041904,Up-Regulation (Physiology)
C0052432,artesunate
C0344315,Depressed mood
C0392756,Reduced
C0458827,Airway structure
C0332161,Attenuated by (contextual qualifier)
C1704419,Effective
C0547044,Smaller
C0851827,Dependent - ability
C0282111,Internet
C0025953,Microbiological
C1522486,Professional Organization or Group
,
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0376223,The Sun
C1442792,State
C2825073,Clearance [PK]
C0441712,Mechanism (attribute)
C0687676,Post
C0441471,Event
C0439227,Hour
C0301872,Immune response
C2745955,Occurrence
C1260953,Suppressed
C0683607,allowing
C0683454,internal-external locus of control scale
C1184743,bony process
C1819437,interleukin-10 production
C0205087,Late
C4281574,Much
C0205469,Pathological aspects
C0031307,Phagocytes
C0398740,Impaired phagocytosis
C0033268,production
C0151521,Bacterial resistance
C0009450,Communicable Diseases
C3900172,A Lot of the Time
C0004623,Bacterial Infections
C0162388,Killing
C0301625,Metabolic Suppression
C1317750,Study report
C1831145,Study report:Finding:Point in time:{Setting}:Document:{Provider}
C0235896,Pulmonary Infiltrate
C0432616,Blood group antibody A
C0332152,Before
C1314939,Involvement with
C0450254,Pathogenic organism
C0884358,Performed
C0332185,Recent
C0439234,year
C1866122,Increased interleukin 10
C0445623,Microorganism
C1705938,Base - General Qualifier
C0185117,Expression procedure
C0332282,Following
C0332162,Onset of (contextual qualifier)
C1880022,Characterization
C0205246,Generalized
C0333348,Inflammatory
C0003209,Anti-Inflammatory Agents
C1515999,Anti-inflammatory effect
C0040300,Body tissue
C0012634,Disease
C2698884,Professional Occupation
C1564907,"Receptors, Pattern Recognition"
C0442805,Increase
C1441547,Derivation
C0205388,Few
C0557775,Van (physical object)
C0439228,day
C0043240,Wound Healing
C0681814,research study
C0521009,Bacterial
C0024109,Lung
C1550516,Target Awareness - partial
C0347984,During
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0009450,Communicable Diseases
C0449913,System
C0441509,Coagulation procedure
C0205082,Severe (severity modifier)
C1879547,Activation action
C0275524,Coinfection
C0017110,Gases
C0442808,Increasing
C0443264,Modulated
C0032285,Pneumonia
C0038172,Staphylococcus aureus
C0040048,Thromboplastin
C0042769,Virus Diseases
C1515877,activate biological process
C0027950,neutrophil
C0439662,Immune
C0522224,Paralysed
C2905612,Storm NOS
C3671956,Cellular infiltration of lung
C1441547,Derivation
C1418736,POLL gene
C0557775,Van (physical object)
C0678226,Due to
C0332283,Followed by
C0004611,Bacteria
C1290884,Inflammatory disorder
C0010957,Tissue damage
C1155266,Inflammatory Response
C0185117,Expression procedure
C0205231,Extensive
C1522538,Leading
C0037179,Unmarried person
C0861064,lead increased
C0521009,Bacterial
C1880022,Characterization
C1880177,Contribution
C0424295,Hyperactive behavior
C0871261,Response process
C1442792,State
C1269955,Tumor Cell Invasion
C1457868,Worse
C0024109,Lung
C0035647,Risk
C1254351,Pharmacologic Substance
C1524003,Science of Etiology
C0079189,cytokine
C0031847,physiopathological
C0038410,Streptococcus pneumoniae
C1555582,Initial (abbreviation)
C2349975,Enhance (action)
C0332162,Onset of (contextual qualifier)
C1704913,TAF1 wt Allele
C0005779,Blood Coagulation Disorders
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0030664,Pathology
C0040300,Body tissue
C0332257,Including (qualifier)
C0010957,Tissue damage
C1536403,pathologic cytolysis
C0021368,Inflammation
C1280500,Effect
C2349975,Enhance (action)
C0521009,Bacterial
C0027950,neutrophil
C0040549,Toxin
C0024109,Lung
C0026566,Aspects of mortality statistics
C0004611,Bacteria
C0678227,Causing
C1947931,Direct (qualifier)
C1167395,Host (organism)
C1416602,KCNMA1 gene
C0023504,Leukocidins
C0023529,"Leukomalacia, Periventricular"
C0210666,Panton-Valentine leukocidin
C1883727,Taken
C1883357,Together
C1149789,agmatinase activity
C2261241,alpha-toxin activity
C0071313,"plY protein, Streptococcus pneumoniae"
C0017107,Gas Poisoning
C1273342,Epithelial cell count (procedure)
C0010868,Cytotoxin
C1414504,F2 gene
C0026538,Morbidity - disease rate
C1853685,PBRM1 gene
C0004630,Bacterial Toxins
C0450254,Pathogenic organism
C0033684,Proteins
C0332281,Associated with
C1327413,cytokine production
C1880177,Contribution
C1314939,Involvement with
C1274040,Result
C0162493,Transcriptional Activation
C0041904,Up-Regulation (Physiology)
C2698977,Capability
C1879547,Activation action
C2346866,Assortment
C2348269,Dietary Lead
C0439662,Immune
C1522538,Leading
C0205082,Severe (severity modifier)
C1301808,Geographic state
C2986495,Synergistic
C0205431,Formed
C1325742,Pore
C1524003,Science of Etiology
C0038170,Genus staphylococcus
C0205250,High
C0521026,Viral
C1047769,Castanea crenata
C0086597,Mediate
C2963249,Accessory
C0304497,Cytotoxic agent (product)
C0386482,purinoceptor P2Z
C0151683,Neutrophilia (finding)
C0750501,most likely
C1527036,Recombinant Chemokine
C0442821,Strong
C0042776,Virus
C0333348,Inflammatory
C1705987,Pathway (interactions)
C0033414,Promotion (action)
C0033382,proline
C1510827,Affinity
C0038410,Streptococcus pneumoniae
C0205251,low
C0041260,Tryptophanase
C1704324,Scientific Publication
C0086418,Homo sapiens
C0683949,Animal Study
C0162443,Journal
C0947630,Scientific Study
C0026809,Mus
C2603343,Study
C0031843,physiological aspects
C0205250,High
C0202311,Aluminum measurement
C0871208,Rating (action)
C3161035,Model
C0024660,Mammals
C4319622,76
C2827396,Scientific Equipment
C0206034,"Clinical Trials, Randomized"
C0032285,Pneumonia
C0332232,Approximate
C0205419,Variant
C0040028,"Thrombocythemia, Essential"
C0085732,Ability
C0003062,Animals
C0521009,Bacterial
C0012984,Canis familiaris
C1707455,Comparison
C0887965,Experimental Animal Models
C0015859,Ferrets
C0206414,"Genes, Reporter"
C0017387,Genetic Engineering
C0205396,Identified
C0301872,Immune response
C0332257,Including (qualifier)
C1522538,Leading
C1517945,Loss
C1521743,"Monitor, occupation"
C0205393,Most
C0324889,Old World rabbit
C1518614,Organism Strain
C0030362,Papio
C0034037,Publishing
C1882932,Representation (action)
C0035804,Rodent
C1135183,Sus scrofa
C1273517,Used by
C0683607,allowing
C0748864,small size
C1947946,Aim (idea)
C0042769,Virus Diseases
C0332287,In addition to
C2981279,Decade
C1832073,Handling
C1551969,Mono language
C0205463,Physiological
C1705920,Species
C1274040,Result
C1706852,Article
C3714514,Infection
C0205453,Seven
C0178693,human study
C1524063,Use of
C0339951,pneumonia organism nos
C1515981,And
C0392360,Indication of (contextual qualifier)
C0376554,Knowledge
C0441712,Mechanism (attribute)
C1514583,Proximity
C0871532,tool use
C0205173,Duplicate
C0232370,Florid red complexion (finding)
C1825598,IMPACT gene
C0040710,Translating
C2700149,Value Above Reference Range
C0220784,anatomic
C2346866,Assortment
C0552371,Citation
C0009924,Contrast Media
C0750480,Count
C3812801,Immunogenicity Specimen Assessments Domain
C0442805,Increase
C2347635,Population Median
C0849355,Removed
C0684224,Report (document)
C1514863,Reproducibility
C0242481,Research Activities
C3853906,Digital Model Attachment
C1280500,Effect
C0332183,Frequently
C0205172,More
C0205171,Singular
C1517741,Last
C0036397,Science
C3827682,Useful
C0042333,Variation (Genetics)
C2827735,2+ Score
C0231242,Complicated
C0205231,Extensive
C0549177,Large
C0456962,Rapid
C0035150,Reproduction
C0547044,Smaller
C0598312,DNA Replication
C1512692,Inbred Strain
C0019247,Hereditary Diseases
C0871261,Response process
C1522424,A Mouse
C0869040,use studies
C1515655,In Vivo
C0314732,Infectious agent
C1707391,Choose (action)
C1522508,Details
C0017398,Science of genetics
C0042153,utilization qualifier
C3826168,Human physiology
C0470187,Availability of
C0034760,Reagents
C1948059,Constant (qualifier)
C0332464,Widening
C1705242,Different
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0026809,Mus
C0009450,Communicable Diseases
C0015859,Ferrets
C0332257,Including (qualifier)
C0086418,Homo sapiens
C0521009,Bacterial
C0042769,Virus Diseases
C1547282,Show
C0684224,Report (document)
C1167395,Host (organism)
C1521797,transmission process
C0439663,Infected
C0450254,Pathogenic organism
C0220898,Predisposition -- attribute
C0221138,Blood group antibody I
C0439070,Roman Numeral III
C0205171,Singular
C0554249,Smith (occupation)
C0041260,Tryptophanase
C0120446,guanidine
C0004611,Bacteria
C0275524,Coinfection
C2827758,Antimicrobial Susceptibility Result
C0470187,Availability of
C2349975,Enhance (action)
C1274040,Result
C0332287,In addition to
C0205082,Severe (severity modifier)
C0557775,Van (physical object)
C0439801,Limited (extensiveness)
C0021400,Influenza
C3853906,Digital Model Attachment
C0005595,Aves
C1521751,C57BL/6 Mouse
C0009924,Contrast Media
C0332218,Difficult (qualifier value)
C1881534,Make - Instruction Imperative
C0025919,"Mice, Inbred BALB C"
C1709305,Occur (action)
C0884358,Performed
C0871133,Priming
C1999230,Providing (action)
C0242481,Research Activities
C0439793,Severities
C0036866,Sex Characteristics
C1336445,Stage IV Uveal Melanoma AJCC v7
C1135183,Sus scrofa
C1524063,Use of
C5141341,Viral strain
C0599779,Animal Model
C0038160,Staphylococcal Infections
C0042333,Variation (Genetics)
C2020625,Group B Streptococcal Infection
C0449295,Limitation
C0599739,synergism
C0439234,year
C4760069,Microbiology - bacterial studies:Finding:Point in time:^Patient:Document
C0041912,Upper Respiratory Infections
C0332283,Followed by
C0521118,Non-infected
C0003062,Animals
C3245499,Colombia
C1764827,Isolate - microorganism
C4313322,Alveolar damage
C1155266,Inflammatory Response
C3842396,No difference
C1511036,Bacterial Model
C2708283,Clinical presentation
C0175668,Secondary to
C0332268,Lacking
C0178849,species difference
C0861064,lead increased
C0740175,Before values
C1707455,Comparison
C1511649,DBA/2 Mouse
C0013682,Efficiency
C0205224,Essential
C1825598,IMPACT gene
C0439662,Immune
C0231185,Inefficient
C0205409,Isolated
C0205393,Most
C0522224,Paralysed
C1273517,Used by
C0449297,Clearance
C0233820,Insight
C1522538,Leading
C0449450,Presentation
C2348205,Similarity
C1441672,Observed
C0814423,accessibility
C0343537,Specific viral infections
C1880022,Characterization
C4289767,Colonization
C0205250,High
C0456178,Microbiology subtype strains
C1514892,Resistance Process
C1515655,In Vivo
C1521846,"Permissiveness, Biological Function"
C0021289,"Infant, Newborn"
C0205172,More
C0068899,NOAC protocol
C0439064,Numerous
C0332185,Recent
C1704241,complex (molecular entity)
C0600661,Outlines (document)
C1523987,Alternative
C0521026,Viral
C0392673,Adaptation
C1518422,Negation
C0439601,Seasonal course
C3540840,Sign or Symptom
C1621797,Garcia <plant>
C0458578,Upper respiratory tract
C0004623,Bacterial Infections
C4321249,DIAPH3 wt Allele
C1706450,Legal Adult
C0205447,One
C0027361,Persons
C0038410,Streptococcus pneumoniae
C2603343,Study
C0332289,Transmitted by
C1280464,Manifestation of
C0445623,Microorganism
C0332162,Onset of (contextual qualifier)
C0311392,Physical findings
C0032285,Pneumonia
C1257890,Population Group
C3827682,Useful
C0332452,defective
C1552740,Entity Determiner - specific
C0034760,Reagents
C0443318,Sustained
C0597357,receptor
C1517320,From
C0029235,Organism
C0012634,Disease
C0038170,Genus staphylococcus
C0549177,Large
C0085979,Cavia
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0024109,Lung
C0439663,Infected
C0205171,Singular
C0032285,Pneumonia
C0086418,Homo sapiens
C0036638,Sendai virus
C1524063,Use of
C0029235,Organism
C0332158,Contact with
C1273517,Used by
C1518422,Negation
C0003062,Animals
C0876973,Infectious Lung Disorder
C0038410,Streptococcus pneumoniae
C0205210,Clinical
C0242781,disease transmission
C3853906,Digital Model Attachment
C0032639,Pontine structure
C0085732,Ability
C0439661,Acquired (qualifier value)
C0004096,Asthma
C0005595,Aves
C0337189,Cage device
C0868928,Case (situation)
C0999699,Cavia porcellus
C0024117,Chronic Obstructive Airway Disease
C4036459,Contacts
C0015272,Exhibits as Topic
C0332183,Frequently
C1515657,In Vivo Model
C0332257,Including (qualifier)
C0205263,Induce (action)
C0029345,"Orthomyxovirus Type A, Porcine"
C0031842,Physiology
C0332289,Transmitted by
C0041260,Tryptophanase
C0458578,Upper respiratory tract
C0042774,Virus Replication
C1704712,Can - object
C1444104,Penicillin resistant Streptococcus pneumoniae
C0470187,Availability of
C3245499,Colombia
C0009450,Communicable Diseases
C0020056,Housing
C0332287,In addition to
C0439234,year
C2347012,Billion Colony Forming Units
C0275524,Coinfection
C0392360,Indication of (contextual qualifier)
C1555389,"Instillation, intratracheal"
C0032269,Pneumococcal Infections
C4505065,Noncommunicable Diseases
C1457887,Symptoms
C0004610,Bacteremia
C1331418,Comfort
C0015859,Ferrets
C0301872,Immune response
C3812801,Immunogenicity Specimen Assessments Domain
C0449719,Part
C0220898,Predisposition -- attribute
C0052432,artesunate
C1512513,Human Pathology
C0332293,Treated with
C0442726,Detected (finding)
C0013682,Efficiency
C0442118,Intranasal approach
C0242481,Research Activities
C0042196,Vaccination
C0043227,Work
C1707887,Efficacy Study
C0004611,Bacteria
C0439792,Extent
C0439793,Severities
C0002808,Science of Anatomy
C1522326,Treating
C1260875,mating
C0332268,Lacking
C0450254,Pathogenic organism
C0033414,Promotion (action)
C0015127,Etiology aspects
C1705232,Death Related to Adverse Event
C0332185,Recent
C0680536,commercial
C0205423,Certain (qualifier value)
C0026193,Minor (person)
C4517892,85
C0314732,Infectious agent
C4517888,83
C1511726,Data
C0678226,Due to
C0034760,Reagents
C0564385,/hour
C0003232,Antibiotics
C0332155,Did not receive therapy or drug for
C0220825,Evaluation
C0205281,Invasive
C1704913,TAF1 wt Allele
C0037783,Species Specificity
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0034693,Rattus norvegicus
C0038410,Streptococcus pneumoniae
C0332257,Including (qualifier)
C1518422,Negation
C0034695,"Rats, Cotton"
C0003062,Animals
C0205172,More
C0028429,Nose
C0040300,Body tissue
C3812881,Author
C0009450,Communicable Diseases
C0851827,Dependent - ability
C3826426,Dynamics
C0332219,Easy
C0205435,First (number)
C0332183,Frequently
C0086418,Homo sapiens
C0020672,"Hypothermia, natural"
C0020971,Immunization
C1512692,Inbred Strain
C0728899,Intoxication
C1292732,Investigates
C0023890,Liver Cirrhosis
C0458579,Lower respiratory tract structure
C0024109,Lung
C0524620,Metabolic Syndrome X
C1518614,Organism Strain
C0450254,Pathogenic organism
C0032285,Pneumonia
C0332185,Recent
C0700287,Reporting
C0443289,Revealed
C0339952,Secondary bacterial pneumonia
C0237876,Sharing (Social Behavior)
C4048236,Sigmodon hispidus
C0205171,Singular
C0032308,Staphylococcal Pneumonia
C0041260,Tryptophanase
C1273517,Used by
C0042776,Virus
C0748168,Pulmonary Pathology
C0917903,Conclude Resin
C0231835,Tachypnea
C0000934,Acclimatization
C0332287,In addition to
C0022702,Kinetics
C0677042,Pathology processes
C1136170,Virulence Factors
C4760069,Microbiology - bacterial studies:Finding:Point in time:^Patient:Document
C0876973,Infectious Lung Disorder
C2911645,"Weight Loss, CTCAE"
C1262477,Weight decreased
C0470187,Availability of
C3161035,Model
C0042774,Virus Replication
C3900172,A Lot of the Time
C1550369,Performed By
C0220898,Predisposition -- attribute
C1883725,Replicate
C0023104,Kilham Rat Virus
C0001807,Aggressive behavior
C1825598,IMPACT gene
C1947932,Smear - instruction imperative
C0010957,Tissue damage
C1282910,Upper
C0042769,Virus Diseases
C0337189,Cage device
C3245499,Colombia
C1707491,Consecutive
C1527148,Development
C0205231,Extensive
C0332268,Lacking
C1708698,Light Emitting Diode Device
C3828842,Nearly
C0682323,Partner in relationship
C0205452,Six
C0332289,Transmitted by
C0439228,day
C0033268,production
C0439230,week
C2603343,Study
C0521026,Viral
C1181296,Epithelium of bronchiole
C0206545,Human respiratory syncytial virus
C0549177,Large
C0205465,Bacteriologic
C0439064,Numerous
C0947630,Scientific Study
C0205251,low
C0521009,Bacterial
C0205246,Generalized
C0028128,nitric oxide
C0011849,Diabetes Mellitus
C1706450,Legal Adult
C1705920,Species
C1521970,Characteristics
C0332282,Following
C0439662,Immune
C1720294,On (qualifier value)
C0034760,Reagents
C0205369,Specific qualifier value
C0038402,Streptococcus
C0024432,macrophage
C0542339,Inferior
C3151529,Lethal
C1274040,Result
C0324889,Old World rabbit
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0205171,Singular
C0041260,Tryptophanase
C0038410,Streptococcus pneumoniae
C0324888,Sylvilagus
C1273517,Used by
C0009450,Communicable Diseases
C0347985,During values
C2826234,Clinical Trial Branch
C0443289,Revealed
C2603343,Study
C0003261,Antibody Formation
C3538928,Usual
C3853906,Digital Model Attachment
C1261322,Evaluation procedure
C0205447,One
C0242481,Research Activities
C0543483,pathogenic aspects
C3161035,Model
C0947630,Scientific Study
C1272684,Accepted
C0242726,Plant Roots
C0082274,diclofenac epolamine
C0020965,Active immunity
C0003062,Animals
C0470187,Availability of
C0004611,Bacteria
C0038952,Continuance of life
C0332219,Easy
C0014003,Employment
C0887898,Experimental Lung Inflammation
C0332282,Following
C0332183,Frequently
C0332257,Including (qualifier)
C0332448,Infiltration
C1704686,Initiation
C1292732,Investigates
C0458579,Lower respiratory tract structure
C0024109,Lung
C1881534,Make - Instruction Imperative
C0032285,Pneumonia
C0850310,Possessed
C0150312,Present
C0522498,Rare
C0229671,Serum
C0032308,Staphylococcal Pneumonia
C0205410,Sufficient
C0038895,Surgical aspects
C0042210,Vaccines
C0748168,Pulmonary Pathology
C1707887,Efficacy Study
C2584321,Reaching
C0876973,Infectious Lung Disorder
C2985574,Study Condition
C0013682,Efficiency
C0015392,Eye
C1424276,HM13 gene
C0018510,Haiti
C0022702,Kinetics
C0449444,Route
C0243026,Sepsis
C0439234,year
C2713348,Virus Titer
C0042774,Virus Replication
C0007226,Cardiovascular system
C3887509,Rabbits
C0034760,Reagents
C0521978,Susceptibility to infections
C0013175,Drug Evaluation
C0449381,Observation parameter
C0155862,Streptococcal pneumonia
C0235896,Pulmonary Infiltrate
C1533734,Administration procedure
C1515981,And
C0439227,Hour
C0884358,Performed
C3844714,No improvement
C1705938,Base - General Qualifier
C1442216,Bronchial system
C0277793,Onset of illness
C0521108,Recovering from
C1705187,Safety Study
C3827682,Useful
C0205170,Good
C0205309,Known
C0700364,Appearance
C0178602,Dosage
C1265611,Quantity
C1513491,Most Recent
C0441729,Type 1
C0003241,Antibodies
C1705232,Death Related to Adverse Event
C0205388,Few
C0013227,Pharmaceutical Preparations
C0332185,Recent
C0678756,drug concentration
C0037783,Species Specificity
C0439064,Numerous
C0442027,Oral
C0205251,low
C0439787,Out (direction)
C0034754,Reading (activity)
C2987620,Inoculation
C0035736,"RNA, Viral"
C4321249,DIAPH3 wt Allele
C0205535,Inhalation Route of Drug Administration
C0086045,Mental concentration
C0005595,Aves
C0205435,First (number)
C0023516,Leukocytes
C1720294,On (qualifier value)
C0042153,utilization qualifier
C0549177,Large
C0205341,Repeat
C0040578,Trachea
C0024400,Macaca mulatta
C0024398,Macaca
C4697068,ADAPTABLE
C1882932,Representation (action)
C1273517,Used by
C0024399,Macaca fascicularis
C1705920,Species
C4505065,Noncommunicable Diseases
C0178693,human study
C0033147,Primates
C0205164,Major
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0024398,Macaca
C0016627,Influenza in Birds
C1518614,Organism Strain
C0580264,H1N1
C0041260,Tryptophanase
C0024399,Macaca fascicularis
C1273517,Used by
C0332185,Recent
C1274040,Result
C1615608,Pandemics
C0450254,Pathogenic organism
C0805586,Challenge
C0205250,High
C0936012,Analysis
C1707455,Comparison
C1279919,Early
C0206277,Fatal Outcome
C0015967,Fever
C1167395,Host (organism)
C1875400,ISOLATE COMPOUND
C0332257,Including (qualifier)
C0205081,Moderate (severity modifier)
C0026809,Mus
C0264515,"Pneumonia, Necrotizing"
C0035222,"Respiratory Distress Syndrome, Adult"
C0042774,Virus Replication
C1547282,Show
C0748355,Acute respiratory distress
C1112870,Aerosol Dose Form
C0541749,Does turn (finding)
C0947630,Scientific Study
C0205210,Clinical
C0542339,Inferior
C1555391,"Instillation, nasal"
C2827758,Antimicrobial Susceptibility Result
C0178602,Dosage
C0444956,High dose
C0599779,Animal Model
C0231180,Insufficient (qualifier)
C1522538,Leading
C1545588,Protection
C0442726,Detected (finding)
C0439663,Infected
C1257890,Population Group
C1334016,High Grade Lesion
C1148523,Childbirth
C0205195,Combined
C2603343,Study
C0543483,pathogenic aspects
C0004048,Inspiration function
C0205449,Three
C0439858,Conventional
C0012634,Disease
C1414262,EDNRA gene
C1155328,Antiviral Response
C0347985,During values
C0449444,Route
C1704913,TAF1 wt Allele
C0042776,Virus
C0205251,low
C1707391,Choose (action)
C0015859,Ferrets
C0030664,Pathology
C1520022,Virulent
C0205263,Induce (action)
C0748132,PULMONARY causes
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C1518422,Negation
C0024399,Macaca fascicularis
C0205210,Clinical
C1290325,Disorder of lower respiratory system
C0086418,Homo sapiens
C0748168,Pulmonary Pathology
C0009450,Communicable Diseases
C1441672,Observed
C1521970,Characteristics
C0032285,Pneumonia
C0023529,"Leukomalacia, Periventricular"
C1521733,Pathologic
C0936012,Analysis
C0005774,Blood Chemical Analysis
C0442726,Detected (finding)
C0580267,H3N2
C0879240,Nasal Swabs
C0522498,Rare
C1273517,Used by
C1524003,Science of Etiology
C4283847,Lung Progression GvHD
C1522642,Clone
C0149725,Lower respiratory tract infection
C0178693,human study
C1257890,Population Group
C0752248,Gene Expression Profiling
C0033147,Primates
C1261322,Evaluation procedure
C0024398,Macaca
C0026447,Monkeys
C1880177,Contribution
C1517586,Investigational
C1314939,Involvement with
C0884358,Performed
C0031350,Pharyngitis
C2603343,Study
C0449381,Observation parameter
C4698075,Virulent strain
C0003062,Animals
C3853906,Digital Model Attachment
C1521743,"Monitor, occupation"
C0554628,Group A Streptococcal Infections
C0017110,Gases
C2945599,Mild (qualifier value)
C3151529,Lethal
C0242481,Research Activities
C0445247,Same
C0205465,Bacteriologic
C1299392,Mild to moderate
C0205127,Longitudinal
C4330475,Immune Cell
C5139167,Severe infection
C0275524,Coinfection
C0038172,Staphylococcus aureus
C0028128,nitric oxide
C0006285,Bronchopneumonia
C0205082,Severe (severity modifier)
C0035243,Respiratory Tract Infections
C0332282,Following
C0024109,Lung
C3898900,Healthy
C0439601,Seasonal course
C1279919,Early
C0205250,High
C1704913,TAF1 wt Allele
,
,
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0003062,Animals
C0024400,Macaca mulatta
C0038410,Streptococcus pneumoniae
C0032285,Pneumonia
C0021270,Infant
C0947630,Scientific Study
C0024398,Macaca
C0205171,Singular
C0805586,Challenge
C1518614,Organism Strain
C0358314,Pneumococcal vaccine
C0071313,"plY protein, Streptococcus pneumoniae"
C0205454,Eight
C0205263,Induce (action)
C0305065,Polyvalent pneumococcal vaccine
C0027442,Nasopharynx
C0025516,"Metabolic Detoxication, Drug"
C0936012,Analysis
C3812881,Author
C4289767,Colonization
C0699809,Does carry
C2987476,Exist
C0332183,Frequently
C3840786,Greatly
C0020964,Immunity
C0332257,Including (qualifier)
C1518422,Negation
C0309872,PREVENT (product)
C0031842,Physiology
C0750492,Probably
C0039593,Testing
C0392366,Tests (qualifier value)
C0087111,Therapeutic procedure
C0041260,Tryptophanase
C0042196,Vaccination
C0033107,prevention & control
C0917903,Conclude Resin
C0220825,Evaluation
C0443640,Specific antibody
C0221138,Blood group antibody I
C0184959,Instillation (procedure)
C1257890,Population Group
C0687676,Post
C1707887,Efficacy Study
C0961101,23-valent pneumococcal capsular polysaccharide vaccine
C0042210,Vaccines
C2936404,Bacterial Load
C1261322,Evaluation procedure
C1273517,Used by
C2987125,Past Week
C0428479,Protein level - finding
C3842585,60%
C1515981,And
C1707101,CD44 wt Allele
C1516240,Capacity
C0439230,week
C2981279,Decade
C1167395,Host (organism)
C0871208,Rating (action)
C3853906,Digital Model Attachment
C0549184,None
C1514583,Proximity
C1825598,IMPACT gene
C1517892,Links List
C0946326,pulmonary studies
C0004927,Behavior
C0038951,Surveys
C3152625,Pneumococcal 13-valent conjugate vaccine
C1519614,Genetic Translation Process
C0445247,Same
C1947989,Colony (cells or organisms)
C3495559,Juvenile arthritis
C0033684,Proteins
C0385592,histidine triad protein
C0678226,Due to
C0682638,Memory B-Lymphocyte
C0001551,Immunologic Adjuvants
C0205296,Natural
C0205435,First (number)
C0205170,Good
C0456981,Specific antigen
C0205448,Two
C0332174,Weekly
C0542559,contextual factors
C0587267,Closed
C0086418,Homo sapiens
C3245505,Potential
C1449520,Pulmonal S
C4527371,Candidate
C0086418,Homo sapiens
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C1135183,Sus scrofa
C0332257,Including (qualifier)
C0025914,House mice
C0039005,Family suidae
C0026473,Monocytes
C1704691,FCGR3A wt Allele
C1367477,CD14 gene
C0009450,Communicable Diseases
C0041260,Tryptophanase
C0020962,Immune system
C0205396,Identified
C2825142,Experimental Result
C1707391,Choose (action)
C1883712,Add - instruction imperative
C0542341,Function (attribute)
C2348205,Similarity
C0032285,Pneumonia
C1335144,Orthologous Gene
C0150312,Present
C0445604,Subclass
C0439662,Immune
C1553343,Chamorro race
C2603343,Study
C1555710,Act Class - Attestable unit
C1698756,"CXCL8 protein, human"
C1706256,Clinical Study Case
C0332219,Easy
C0887965,Experimental Animal Models
C0332183,Frequently
C0209606,Integrin alpha4beta1
C0079717,Lymphocyte Function-Associated Antigen-1
C0024501,Maintenance
C0040421,Palatine Tonsil
C0031842,Physiology
C0850310,Possessed
C0033147,Primates
C0035804,Rodent
C0327949,Salmo salar
C0237876,Sharing (Social Behavior)
C4048302,"T-Lymphocyte Activation Antigen CD80, human"
C0449851,Techniques
C2936411,Th17 Cells
C3538928,Usual
C3640076,Whole Genome Sequencing
C1522005,immunology aspects
C2985420,CD276 Antigen
C0007578,Cell Adhesion Molecules
C0439092,Less Than
C4330475,Immune Cell
C1521970,Characteristics
C0024660,Mammals
C1518601,Options
C0178784,Organ
C0079189,cytokine
C0681797,paradigm
C0458578,Upper respiratory tract
C0947630,Scientific Study
C2349967,Compartment of cell
C1515657,In Vivo Model
C3178847,Genome Size
C0392920,Chemotherapy Regimen
C1622714,attractant
C4722001,Substance with effector mechanism of action (substance)
C3842590,10%
C3842583,80%
C0332197,Absent
C1705938,Base - General Qualifier
C1314939,Involvement with
C1423842,NELFCD gene
C0871261,Response process
C1552738,described
C0868920,human anatomy
C4253999,Nasopharyngeal lymphoid tissue
C4699274,>50 cells
C0026339,Biological Models
C0332529,Consistency
C0332849,Divide
C1552740,Entity Determiner - specific
C0205450,Four
C1334043,Homologous Gene
C2347617,Point Name
C0205449,Three
C1524063,Use of
C0012655,Disease susceptibility
C0205108,Distal (qualifier value)
C0036849,Set (Psychology)
C3272444,PIGA wt Allele
C0205170,Good
C0205309,Known
C0205393,Most
C3842584,70%
C0175630,Circulating
C0521447,Nuclear (nucleus)
C0027950,neutrophil
C2347957,Reservation (action)
C1555712,topic - ActClassContainer
C1267822,CD4+ CD25+ Regulatory T Cells
C2350008,Financial (qualifier)
C0700321,Small
C1522138,shared attribute
C2827755,Antimicrobial Intermediate Susceptibility Result
C0439858,Conventional
C1551910,Dawson Language
C0231193,adaptive
C0333348,Inflammatory
C0523852,Proline measurement
C0205402,Prominent
C0442824,Very
C1167395,Host (organism)
C0599779,Animal Model
C0449911,View
C0205470,immunologic
C0028128,nitric oxide
C0443225,Full
C2945640,compromise
C0003062,Animals
C0005532,biology (field)
C0017296,gene therapy
C0006539,Belarus
C0205082,Severe (severity modifier)
C1548787,Appropriate
C4321249,DIAPH3 wt Allele
C1705242,Different
C2698651,Optimum
C0332464,Widening
C0450254,Pathogenic organism
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C1135183,Sus scrofa
C0029235,Organism
C1708698,Light Emitting Diode Device
C0035243,Respiratory Tract Infections
C0042196,Vaccination
C3714514,Infection
C0557775,Van (physical object)
C3853906,Digital Model Attachment
C0086418,Homo sapiens
C0003869,"Arthritis, Infectious"
C0006017,Bordetella pertussis
C1300203,Genus Homo
C0580264,H1N1
C0580267,H3N2
C0332257,Including (qualifier)
C1881534,Make - Instruction Imperative
C0026926,Mycobacterium tuberculosis
C0029443,Osteomyelitis
C0033809,Pseudomonas aeruginosa
C0036690,Septicemia
C1547282,Show
C0038172,Staphylococcus aureus
C0038410,Streptococcus pneumoniae
C0041260,Tryptophanase
C1273517,Used by
C0543483,pathogenic aspects
C2708283,Clinical presentation
C0275524,Coinfection
C0332281,Associated with
C0332287,In addition to
C3245499,Colombia
C1948053,Period (temporal qualifier)
C0004610,Bacteremia
C4289767,Colonization
C0015967,Fever
C0205280,Identical
C0439663,Infected
C0884358,Performed
C0332185,Recent
C0242481,Research Activities
C0449560,Subtype (attribute)
C0439234,year
C0443211,Established
C0205170,Good
C0237753,Numbers
C0439228,day
C1442466,5 Days
C1707959,Example
C0043241,Wound Infection
C1412493,AQP3 gene
C0391936,Barbiturates measurement
C2348205,Similarity
C0521346,respiratory
C0011198,Delaware
C0009450,Communicable Diseases
C0442118,Intranasal approach
C0348016,Intravenous
C3540840,Sign or Symptom
C1704913,TAF1 wt Allele
C4321249,DIAPH3 wt Allele
C1512612,Ideal
C0947630,Scientific Study
C0678227,Causing
C1707491,Consecutive
C0521125,Preposition For
C0205452,Six
C0450254,Pathogenic organism
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0565930,per second
C0041260,Tryptophanase
C1135183,Sus scrofa
C0861352,Lobular Neoplasia
C0450254,Pathogenic organism
C0439663,Infected
C0086418,Homo sapiens
C0003864,Arthritis
C0015127,Etiology aspects
C0332257,Including (qualifier)
C0025289,Meningitis
C0243026,Sepsis
C0947630,Scientific Study
C3853906,Digital Model Attachment
C0332287,In addition to
C0034036,Publications
C0039005,Family suidae
C3245499,Colombia
C0439801,Limited (extensiveness)
C0004611,Bacteria
C0332183,Frequently
C0017337,Genes
C0017420,Genitalia
C0205250,High
C1512612,Ideal
C1115660,Lot Number
C0205393,Most
C1456808,"Nares, entire, anterior or posterior"
C0439064,Numerous
C1948045,Once (schedule frequency)
C0343532,Streptococcal toxic shock syndrome
C0040710,Translating
C1524063,Use of
C3538928,Usual
C0750591,consider
C1547282,Show
C4759886,Apoptosis Pathway
C0868966,Habitations
C0206209,Time Management
C0009450,Communicable Diseases
C1327413,cytokine production
C2708283,Clinical presentation
C0014653,Equilibrium
C0424295,Hyperactive behavior
C0029235,Organism
C1520022,Virulent
C4322223,Mucosa of tonsil
C0085520,Streptococcus suis
C0332281,Associated with
C0017189,Gastrointestinal tract structure
C0301872,Immune response
C1550369,Performed By
C1836348,Severe disorder
C0010186,Financial cost
C0205246,Generalized
C0456178,Microbiology subtype strains
C0449943,Serotype
C0470187,Availability of
C0003062,Animals
C1707455,Comparison
C0023185,Learning
C0032285,Pneumonia
C0681829,in vivo study
C0205409,Isolated
C0025929,Laboratory mice
C0205171,Singular
C0392747,Changing
C1257890,Population Group
C1280500,Effect
C1514873,Requirement
C2986495,Synergistic
C0237753,Numbers
C0205148,Surface
C1514559,Protein Overexpression
C0445623,Microorganism
C1955473,Others - Allergy
C0275524,Coinfection
C1628327,Zoonotic pathogen
C0005639,Bisexuality
C1006780,Citrus maxima
C0333348,Inflammatory
C0024501,Maintenance
C2700149,Value Above Reference Range
C0205172,More
C0205082,Severe (severity modifier)
C0003069,"Animals, Transgenic"
C0580264,H1N1
C0872329,animal facility
C1167395,Host (organism)
C0205296,Natural
C0332185,Recent
C1517586,Investigational
C1704211,Specialized
C0747726,POLY
C0748168,Pulmonary Pathology
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C0009450,Communicable Diseases
C0596171,Tissue Engineering
C0024109,Lung
C0947630,Scientific Study
C0040300,Body tissue
C0332257,Including (qualifier)
C3853906,Digital Model Attachment
C1880177,Contribution
C1519523,Tissue Model
C2603343,Study
C0041260,Tryptophanase
C0819757,Structure of parenchyma of lung
C0440744,Human tissue
C3161035,Model
C1706515,Matrix substance
C0748168,Pulmonary Pathology
C0332185,Recent
C1442459,3 Days
C1704241,complex (molecular entity)
C0221908,Epithelial
C0178784,Organ
C0029250,Organoids
C0011306,Dendritic Cells
C0014323,Entamoeba histolytica
C0014834,Escherichia coli
C0038170,Genus staphylococcus
C0439267,Gram per Deciliter
C0441835,Group A (qualifier value)
C0205263,Induce (action)
C1550608,Instance
C0023529,"Leukomalacia, Periventricular"
C0026473,Monocytes
C4706659,Necrotizing pneumonia caused by Panton-Valentine leukocidin producing Staphylococcus aureus
C0031669,Phospholipase C
C1979971,Russell
C0038402,Streptococcus
C0449911,View
C0750591,consider
C0024432,macrophage
C0027950,neutrophil
C1705535,suggestion
C1321301,Peripheral blood mononuclear cell (cell)
C0038166,Staphylococcal Skin Infections
C4330475,Immune Cell
C0003737,Architecture
C0007585,Cell Culture Techniques
C0486616,Composition
C1280477,Progress
C0034036,Publications
C1704458,Top (position)
C1720176,Upon - dosing instruction fragment
C3539073,In the Field
C1257974,Regenerative Medicine
C0035869,Rotavirus Infections
C1524063,Use of
C0449445,Approach
C0450254,Pathogenic organism
C0934502,anatomical layer
C4082764,Gastrointestinal infection
C0276289,Zika Virus Infection
C0850666,Infection caused by Helicobacter pylori
C1752856,Host-Pathogen Interactions
C0019169,hepatitis B virus
C2827396,Scientific Equipment
C3900053,Amenable
C2347946,Relevance
C2924612,Cephalometric point A
C0242994,Hantavirus Infections
C0162340,Comprehension
C0332529,Consistency
C0014003,Employment
C0016030,Fibroblasts
C3840786,Greatly
C1285542,Has focus
C0237753,Numbers
C0035870,Rotavirus
C1707903,Embedding
C3245505,Potential
C0009325,collagen
C1518422,Negation
C0036397,Science
C0205171,Singular
C0237451,Adaptability
C1280500,Effect
C0441471,Event
C3714514,Infection
C0021852,"Intestines, Small"
C0007634,Cells
C0439064,Numerous
C0750502,Significant
C2348480,ex vivo
C0205393,Most
C0205363,Stratified
C2828392,Standard (document)
C0872351,monolayer
C0439234,year
C0021107,Implantation procedure
C0032285,Pneumonia
C0887913,Andes Virus
C0003048,Animal Experimentation
C0003062,Animals
C0227523,Structure of hepatic sinusoid
C0521362,gastrointestinal
C0736268,Liver parenchyma
C0549177,Large
C1704913,TAF1 wt Allele
C0024348,Lysis
C2625439,Andes
C0439851,Direct type of relationship
C0014609,Epithelium
C0272285,Heparin-induced thrombocytopenia
C0086418,Homo sapiens
C0038351,Stomach
C0205448,Two
C0205090,Right
C0682624,Sinusoid
C0205449,Three
C0542559,contextual factors
,
C0202311,Aluminum measurement
C0040028,"Thrombocythemia, Essential"
C2348480,ex vivo
C1261552,Step (specific stage)
C0086418,Homo sapiens
C0041260,Tryptophanase
C0029345,"Orthomyxovirus Type A, Porcine"
C3714514,Infection
C0445623,Microorganism
C0565930,per second
C0024109,Lung
C0004589,Bacillus anthracis
C0439659,Beginning
C0018483,Haemophilus influenzae
C1752856,Host-Pathogen Interactions
C0332257,Including (qualifier)
C0027552,Needs
C2983310,Overcome
C0884358,Performed
C0033414,Promotion (action)
C0700287,Reporting
C0038410,Streptococcus pneumoniae
C2603343,Study
C1547282,Show
C1515273,Term (temporal)
C0439855,Complex
C1261322,Evaluation procedure
C0332287,In addition to
C0934502,anatomical layer
C0542559,contextual factors
C1550456,option - ActMoodPredicate
C0517627,Infection status
C0449913,System
C0010957,Tissue damage
C0205234,Focal
C0242732,Tropism
C0004623,Bacterial Infections
C0851827,Dependent - ability
C0205393,Most
C1963578,Release (procedure)
C0043227,Work
C2350512,Bacterial Processes
C1524063,Use of
C0521114,Infrequent
C0275524,Coinfection
C0449295,Limitation
C0681814,research study
C2169571,Recent infection
C0871208,Rating (action)
C1524062,Additional
C0205172,More
C0243042,Inflammation Mediators
C0205125,Deep (qualifier value)
C0205435,First (number)
C0205250,High
C1555582,Initial (abbreviation)
C0205281,Invasive
C0127400,Mediator brand of benfluorex hydrochloride
C1514873,Requirement
C0042776,Virus
C0678226,Due to
C0596171,Tissue Engineering
C0185117,Expression procedure
C1325531,Microbial anatomical capsule structure
C0518609,Consideration
C0598312,DNA Replication
C0026531,Morality
C0521009,Bacterial
C2699153,Cell Invasion
C0819757,Structure of parenchyma of lung
C0440744,Human tissue
C0332185,Recent
C0332282,Following
C1522240,Process
C0205448,Two
C0005558,Biopsy
C0178784,Organ
C0039005,Family suidae
C0150312,Present
C3540763,VARIOUS DRUG CLASSES IN ATC
C0439234,year
C1519355,Slice
C0332257,Including (qualifier)
C0205169,Bad
C0009450,Communicable Diseases
C0521009,Bacterial
C0086418,Homo sapiens
C0947630,Scientific Study
C0004611,Bacteria
C0085979,Cavia
C0162340,Comprehension
C0443211,Established
C0442801,Exaggerated
C0015859,Ferrets
C3826168,Human physiology
C0020962,Immune system
C0020969,"Immunity, Innate"
C0449295,Limitation
C3161035,Model
C0026565,Mortality Vital Statistics
C0027552,Needs
C0324889,Old World rabbit
C0032285,Pneumonia
C0150312,Present
C1999230,Providing (action)
C0034721,Rattus
C1706244,Summary (document)
C0041260,Tryptophanase
C1524063,Use of
C0750591,consider
C1705535,suggestion
C1512716,"Infectious Agent, Virus"
C1521761,Factor
C1881534,Make - Instruction Imperative
C3272629,Epithelial Damage
C3853906,Digital Model Attachment
C3151529,Lethal
C2905612,Storm NOS
C0877203,Viral Respiratory Tract Infection
C0729531,Viral respiratory infection
C0015264,Exertion
C1518422,Negation
C0033147,Primates
C0026809,Mus
C0884358,Performed
C2346866,Assortment
C2349975,Enhance (action)
C0376554,Knowledge
C1522538,Leading
C0439849,Relationships
C1522005,immunology aspects
C0220880,morbidity aspects
C0597653,virus infection mechanism
C0332183,Frequently
C3245499,Colombia
C2828008,Burden
C0725066,Advance -- medical device
C0242656,Disease Progression
C1880022,Characterization
C0039005,Family suidae
C0205250,High
C0439064,Numerous
C0079189,cytokine
C1706912,BARRIER
C0205082,Severe (severity modifier)
C1515655,In Vivo
C1456573,Global Health
C1456613,Health systems
C0441712,Mechanism (attribute)
C0205172,More
C5139167,Severe infection
C2986495,Synergistic
C0016884,Future
C4281574,Much
C0332185,Recent
C0439234,year
C2348867,Global
C0449913,System
C0013109,Drama
